May 6, 2026 - 12:36

DENVER, CO - The Senate Business, Labor, and Technology Committee voted unanimously on Wednesday to advance legislation that would create Colorado's first comprehensive regulatory framework for automated decision-making technology. The bill, sponsored by Senate Majority Leader Robert Rodriguez and Senate President James Coleman, both Democrats from Denver, aims to set clear rules for how artificial intelligence and algorithmic systems can be used in decisions that affect people's lives.
The legislation would require companies and government agencies to disclose when they use automated systems to make significant decisions, such as those related to housing, employment, credit, and healthcare. It also establishes requirements for testing these systems to prevent bias and discrimination. Supporters argue the measure is necessary to protect consumers and ensure transparency as AI tools become more common in everyday transactions.
During the committee hearing, several witnesses testified about the potential harms of unregulated algorithms, including cases where automated systems have denied services or misidentified individuals. The bill's sponsors emphasized that Colorado is taking a proactive stance to address these issues before they become widespread problems. The measure now moves to the full Senate for further debate.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...